# US 2018/0021580 A1 · Nerve stimulation for treatment of diseases and disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021580 A1
- Document ID: US20180021580A1
- Status: Published application
- Kind: A1
- Application number: 15/677,080
- Filed: 2017-08-15
- Published: 2018-01-25
- Earliest claimed: 2015-02-20
- Assignees: The Feinstein Institute for Medical Research
- Applicants: The Feinstein Institute for Medical Research
- Inventors: Kevin J. Tracey; Sangeeta S. Chavan
- Web page: https://patentgrep.com/patent/US20180021580A1

## CPC

- A61N 1/36135: {using physiological parameters}
- A61N 1/36002: {Cancer treatment, e.g. tumour}
- A61N 1/36007: {of urogenital or gastrointestinal organs, e.g. for incontinence control}
- A61N 1/36053: {adapted for vagal stimulation (A61N1/36114 takes precedence)}
- A61N 1/36071: {Pain}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Methods are disclosed for treating a subject having a disease or disorder comprising stimulating a nerve of the subject with a corrective stimulus pattern derived from a disease-specific, condition-specific, endogenous mediator-specific or pharmacologic agent-specific neurogram in an amount and manner effective to treat the disease or disorder.

## Claims

### Claim 1

A method for treating a subject having a disease or disorder comprising stimulating a nerve of the subject with a corrective stimulus pattern derived from a disease-specific, condition-specific, endogenous mediator-specific or pharmacologic agent-specific neurogram in an amount and manner effective to treat the disease or disorder.

### Claim 2 (depends on 1)

The method of claim 1, wherein the disease or disorder is one or more of inflammation, type 1 diabetes, type 2 diabetes, metabolic syndrome, insulin resistance, glucose intolerance, hyperglycemia, hypoglycemia, trauma, bleeding, hemorrhagic shock, ischemia-reperfusion injury, nausea, vomiting, cancer, prostate cancer, arthritis, rheumatoid arthritis, sepsis, endotoxemia, colitis, pancreatitis, inflammatory bowel disease, Crohn's Disease, fever, anorexia, pain, swelling, kidney failure, liver disease, hypothyroidism, a host response to infection, an immune response, and a disease or disorder in which it is desirable to increase the activity or level of a cytokine.

### Claim 3 (depends on 1)

The method of claim 1, wherein the disease-specific, condition-specific, endogenous mediator-specific or pharmacologic agent-specific neurogram is obtained using an animal model of the disease or disorder, or from a human patient.

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The method of claim 1, wherein the neurogram is obtained in response to administration of a cytokine or administration of glucagon, glucose or insulin to the subject.

### Claim at position 6

6-7. (canceled)

### Claim 8 (depends on 1)

The method of claim 1, wherein the disease-specific, condition-specific, endogenous mediator-specific or pharmacologic agent-specific neurogram is obtained from the vagus nerve, splenic nerve, splanchnic nerve, sciatic nerve, or a nerve to a specific organ or portion of an organ.

### Claim 9

(canceled)

### Claim 10 (depends on 1)

The method of claim 1, wherein corrective stimulus pattern is applied to the vagus nerve, splenic nerve, splanchnic nerve, sciatic nerve, or a nerve to a specific organ or portion of an organ.

### Claim 11 (depends on 1)

The method of claim 1, wherein a cytokine-specific neurogram is used to induce a cytokine-specific physiological effect.

### Claim 12 (depends on 1)

The method of claim 1 for controlling blood glucose levels in a subject, the method comprising stimulating a cervical vagus nerve of the subject with a corrective stimulus pattern derived from a hypoglycemic- or hyperglycemic-specific neurogram recorded from a vagus nerve in an amount and manner effective to control blood glucose levels in a subject.

### Claim 13 (depends on 12)

The method of claim 12 for decreasing blood glucose levels in a subject comprising stimulating a cervical vagus nerve of the subject with a corrective stimulus pattern derived from a hypoglycemic-specific, insulin-specific or cortisol-specific neurogram recorded from a vagus nerve in an amount and manner effective to decrease blood glucose levels in a subject.

### Claim 14 (depends on 13)

The method of claim 13, wherein the cervical vagus nerve is stimulated with a corrective stimulus pattern derived from a hypoglycemic-specific neurogram recorded from a vagus nerve.

### Claim 15 (depends on 13)

The method of claim 13, wherein the cervical vagus nerve is stimulated with a corrective stimulus pattern derived from an insulin-specific neurogram recorded from a vagus nerve.

### Claim 16

(canceled)

### Claim 17 (depends on 15)

The method of claim 15, wherein the decrease in blood glucose levels is mediated by vagal afferent signaling.

### Claim at position 17

18-21. (canceled)

### Claim 22 (depends on 13)

The method of claim 13, wherein the subject receiving vagus nerve stimulation has one or more of diabetes mellitus type 1, diabetes mellitus type 2, metabolic syndrome, glucose intolerance, insulin resistance and hyperglycemia.

### Claim 23

(canceled)

### Claim 24 (depends on 12)

The method of claim 12 for increasing blood glucose levels in a subject comprising stimulating a cervical vagus nerve of the subject with a corrective stimulus pattern derived from a hperglycemia-specific or glucose-specific neurogram recorded from a vagus nerve in an amount and manner effective to increase blood glucose levels in a subject.

### Claim at position 21

25-27. (canceled)

### Claim 28 (depends on 24)

The method of claim 24, wherein the subject receiving vagus nerve stimulation has one or more of hypoglycemia, kidney failure, liver disease and hypothyroidism.

### Claim 29 (depends on 1)

The method of claim 1 for treating a subject having inflammation, the method comprising stimulating a cervical vagus nerve of the subject with a corrective stimulus pattern derived from an anti-inflammatory cytokine-specific or cortisol-specific or dexamethasone-specific neurogram recorded from a vagus nerve in an amount and manner effective to treat inflammation in a subject.

### Claim at position 24

30-40. (canceled)

### Claim 41 (depends on 29)

The method of claim 29, wherein stimulation of the cervical vagus nerve with a corrective stimulus pattern derived from a cortisol-specific neurogram decreases blood glucose levels in the subject.

### Claim 42 (depends on 1)

The method of claim 1, wherein the corrective stimulus pattern is applied to the vagus nerve and wherein physiologic effects of the corrective stimulus pattern are mediated by vagal nerve afferents.

### Claim 43 (depends on 1)

The method of claim 1, wherein the neurogram is obtained from an animal model or a human patient.

### Claim 44

(canceled)

### Claim 45

A method for generating a corrective stimulus for the treatment of a disease or condition, comprising the steps of:
providing a disease-specific, condition-specific, endogenous mediator-specific or pharmacologic agent-specific neurogram, and
generating a corrective neural stimulus based therefrom.

### Claim at position 30

46-50. (canceled)
